companies: 9,734     total market cap: NZ$179.620 T
$USD🇺🇸€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$HKD🇭🇰$SGD🇸🇬
Alnylam Pharmaceuticals
ALNY
#584
Rank
NZ$56.83 B
Marketcap
🇺🇸 USA
Country
$442.69
Share price
-0.89%
Change (1 day)
49.62%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: NZ$56.83 Billion

As of September 2024 Alnylam Pharmaceuticals has a market cap of NZ$56.83 Billion. This makes Alnylam Pharmaceuticals the world's 584th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$56.83 B49.63%
2023NZ$37.98 B-17.52%
2022NZ$46.05 B55.5%
2021NZ$29.61 B41.06%
2020NZ$20.99 B9.61%
2019NZ$19.15 B74.25%
2018NZ$10.99 B-38.04%
2017NZ$17.74 B282.49%
2016NZ$4.63 B-60.42%
2015NZ$11.71 B22.74%
2014NZ$9.54 B91.29%
2013NZ$4.99 B327.1%
2012NZ$1.16 B161.88%
2011NZ$0.44 B-17.88%
2010NZ$0.54 B-46.86%
2009NZ$1.02 B-42.41%
2008NZ$1.77 B15.69%
2007NZ$1.53 B36.34%
2006NZ$1.12 B198.59%
2005NZ$0.37 B86.71%
2004NZ$0.20 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

NZ$56.83 Billion
by Yahoo Finance info icon info icon
NZ$56.83 Billion
by CompaniesMarketCap info icon info icon
NZ$56.83 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
Arrowhead Pharmaceuticals
ARWR
NZ$4.17 B-92.65%🇺🇸 USA
Regeneron Pharmaceuticals
REGN
NZ$204.02 B 258.98%🇺🇸 USA
Sarepta Therapeutics
SRPT
NZ$19.60 B-65.50%🇺🇸 USA
OPKO Health
OPK
NZ$1.65 B-97.09%🇺🇸 USA
Regulus Therapeutics
RGLS
NZ$0.19 B-99.66%🇺🇸 USA
Novartis
NVS
NZ$379.98 B 568.59%🇨🇭 Switzerland
Sanofi
SNY
NZ$233.51 B 310.88%🇫🇷 France
Teva Pharmaceutical Industries
TEVA
NZ$32.06 B-43.58%🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
 CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com